BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

550 related articles for article (PubMed ID: 25193238)

  • 21. Curcumin Improves Amyloid β-Peptide (1-42) Induced Spatial Memory Deficits through BDNF-ERK Signaling Pathway.
    Zhang L; Fang Y; Xu Y; Lian Y; Xie N; Wu T; Zhang H; Sun L; Zhang R; Wang Z
    PLoS One; 2015; 10(6):e0131525. PubMed ID: 26114940
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protective effects of luteolin against cognitive impairment induced by infusion of Aβ peptide in rats.
    Yu TX; Zhang P; Guan Y; Wang M; Zhen MQ
    Int J Clin Exp Pathol; 2015; 8(6):6740-7. PubMed ID: 26261557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hydroxyurea attenuates oxidative, metabolic, and excitotoxic stress in rat hippocampal neurons and improves spatial memory in a mouse model of Alzheimer's disease.
    Brose RD; Lehrmann E; Zhang Y; Reeves RH; Smith KD; Mattson MP
    Neurobiol Aging; 2018 Dec; 72():121-133. PubMed ID: 30245242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A cAMP analog attenuates beta-amyloid (1-42)-induced mitochondrial dysfunction and spatial learning and memory deficits.
    Aghsami M; Sharifzadeh M; Sepand MR; Yazdankhah M; Seyednejad SA; Pourahmad J
    Brain Res Bull; 2018 Jun; 140():34-42. PubMed ID: 29605485
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synergistic effects of selegiline and donepezil on cognitive impairment induced by amyloid beta (25-35).
    Tsunekawa H; Noda Y; Mouri A; Yoneda F; Nabeshima T
    Behav Brain Res; 2008 Jul; 190(2):224-32. PubMed ID: 18420288
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of Tong Luo Jiu Nao on Aβ-degrading enzymes in AD rat brains.
    Liu Y; Hua Q; Lei H; Li P
    J Ethnopharmacol; 2011 Sep; 137(2):1035-46. PubMed ID: 21798326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SUN11602 has basic fibroblast growth factor-like activity and attenuates neuronal damage and cognitive deficits in a rat model of Alzheimer's disease induced by amyloid β and excitatory amino acids.
    Ogino R; Murayama N; Noshita T; Takemoto N; Toba T; Oka T; Narii N; Yoshida S; Ueno N; Inoue T
    Brain Res; 2014 Oct; 1585():159-66. PubMed ID: 25130662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amyloid-beta causes memory impairment by disturbing the JAK2/STAT3 axis in hippocampal neurons.
    Chiba T; Yamada M; Sasabe J; Terashita K; Shimoda M; Matsuoka M; Aiso S
    Mol Psychiatry; 2009 Feb; 14(2):206-22. PubMed ID: 18813209
    [TBL] [Abstract][Full Text] [Related]  

  • 29. (-)-Epigallocatechin-3-gallate ameliorates memory impairment and rescues the abnormal synaptic protein levels in the frontal cortex and hippocampus in a mouse model of Alzheimer's disease.
    Guo Y; Zhao Y; Nan Y; Wang X; Chen Y; Wang S
    Neuroreport; 2017 Jul; 28(10):590-597. PubMed ID: 28520620
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tetrahydroxystilbene glucoside improves the learning and memory of amyloid-β(₁₋₄₂)-injected rats and may be connected to synaptic changes in the hippocampus.
    Zhou L; Hou Y; Yang Q; Du X; Li M; Yuan M; Zhou Z
    Can J Physiol Pharmacol; 2012 Nov; 90(11):1446-55. PubMed ID: 23181273
    [TBL] [Abstract][Full Text] [Related]  

  • 31. B₂ receptor blockage prevents Aβ-induced cognitive impairment by neuroinflammation inhibition.
    Bicca MA; Costa R; Loch-Neckel G; Figueiredo CP; Medeiros R; Calixto JB
    Behav Brain Res; 2015 Feb; 278():482-91. PubMed ID: 25446751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The nootropic and neuroprotective proline-containing dipeptide noopept restores spatial memory and increases immunoreactivity to amyloid in an Alzheimer's disease model.
    Ostrovskaya RU; Gruden MA; Bobkova NA; Sewell RD; Gudasheva TA; Samokhin AN; Seredinin SB; Noppe W; Sherstnev VV; Morozova-Roche LA
    J Psychopharmacol; 2007 Aug; 21(6):611-9. PubMed ID: 17092975
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Geniposide ameliorates cognitive deficits by attenuating the cholinergic defect and amyloidosis in middle-aged Alzheimer model mice.
    Zhao C; Zhang H; Li H; Lv C; Liu X; Li Z; Xin W; Wang Y; Zhang W
    Neuropharmacology; 2017 Apr; 116():18-29. PubMed ID: 27940040
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oligomeric Amyloid-β Toxicity Can Be Inhibited by Blocking Its Cellular Binding in Cortical Neuronal Cultures with Addition of the Triphenylmethane Dye Brilliant Blue G.
    Jana MK; Cappai R; Ciccotosto GD
    ACS Chem Neurosci; 2016 Aug; 7(8):1141-7. PubMed ID: 27258855
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intranasal formulation of erythropoietin (EPO) showed potent protective activity against amyloid toxicity in the Aβ₂₅₋₃₅ non-transgenic mouse model of Alzheimer's disease.
    Maurice T; Mustafa MH; Desrumaux C; Keller E; Naert G; de la C García-Barceló M; Rodríguez Cruz Y; Garcia Rodríguez JC
    J Psychopharmacol; 2013 Nov; 27(11):1044-57. PubMed ID: 23813967
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simvastatin prevents β-amyloid(25-35)-impaired neurogenesis in hippocampal dentate gyrus through α7nAChR-dependent cascading PI3K-Akt and increasing BDNF via reduction of farnesyl pyrophosphate.
    Wang C; Chen T; Li G; Zhou L; Sha S; Chen L
    Neuropharmacology; 2015 Oct; 97():122-32. PubMed ID: 26051402
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Erythropoietin improves synaptic plasticity and memory deficits by decrease of the neurotransmitter release probability in the rat model of Alzheimer's disease.
    Esmaeili Tazangi P; Moosavi SM; Shabani M; Haghani M
    Pharmacol Biochem Behav; 2015 Mar; 130():15-21. PubMed ID: 25553822
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuronal Protein Tyrosine Phosphatase 1B Hastens Amyloid β-Associated Alzheimer's Disease in Mice.
    Ricke KM; Cruz SA; Qin Z; Farrokhi K; Sharmin F; Zhang L; Zasloff MA; Stewart AFR; Chen HH
    J Neurosci; 2020 Feb; 40(7):1581-1593. PubMed ID: 31915254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beneficial effects of dietary EGCG and voluntary exercise on behavior in an Alzheimer's disease mouse model.
    Walker JM; Klakotskaia D; Ajit D; Weisman GA; Wood WG; Sun GY; Serfozo P; Simonyi A; Schachtman TR
    J Alzheimers Dis; 2015; 44(2):561-72. PubMed ID: 25318545
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Arginine vasopressin prevents amyloid beta protein-induced impairment of long-term potentiation in rat hippocampus in vivo.
    Jing W; Guo F; Cheng L; Zhang JF; Qi JS
    Neurosci Lett; 2009 Feb; 450(3):306-10. PubMed ID: 19059464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.